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a b s t r a c t
The immune system of female H-2b (C57BL/6) mice is a strong responder against the male minor-H
antigen. However rejection or acceptance of suchweaklymismatched grafts depends on the type of tissue
transplanted. The mechanism responsible for such spontaneous graft acceptance, and its relationship to
the natural mechanisms of tolerance of self antigens is unknown. Co-inhibitory molecules negatively
regulate immune responses, and are important for self tolerance. We examined whether co-inhibitory
molecules play a critical role in “spontaneous” allograft tolerance. Naïve or donor sensitized diabetic
female C57BL/6 (B6) wild type (WT), PD-1−/−, and BTLA−/− mice were transplanted with freshly isolated
syngeneic male islet grafts. The role of co-inhibitors during priming of anti-donor responses and graft
challenge was also assessed using monoclonal antibodies targeting co-inhibitory receptors. Among the
co-inhibitor (CTLA-4, PD-1) speciﬁc antibodies tested, only anti-PD-1 showed some potential to prevent
−/− −/−
              
spontaneous acceptance ofmale islet grafts. All BTLA and almost all PD-1 recipientsmaintained the
ability to spontaneously accept male islet grafts. While spontaneous graft acceptance in naïve recipients
was only weakly PD-1 dependent, tolerance induced by the accepted islets was found to be highly PD-1
dependent. Furthermore, spontaneous graft acceptance in pre-sensitized recipients showed an absolute
requirement for recipient PD-1 but not BTLA. Thus, the PD-1 pathway, involved in self tolerance, plays
eous
ancea critical role in spontan
spontaneous graft accept
        
ntroduction
The success ofMHCmatched transplants is impeded by immune
esponses to minor-H antigens (Dierselhuis and Goulmy 2009). For
nstance, bone marrow transplants between HLA matched siblings
nduced GVH disease due to immune responses against minor-
antigens (Simpson et al. 2002). Autosomal and Y-chromosome
enes encodeH-antigens (Simpson and Roopenian 1997). Themale
peciﬁc antigen (HY) triggers rejectionofmale syngeneic skingrafts
n certain inbred strains of female mice (Eichwald and Silmser
955). Naïve H-2b females can reject male skin grafts and thus
Abbreviations: WT, wild type; STZ, streptozotocin; mAb, monoclonal antibody;
VH, graft versus host; PD-1, programmed death-1; BTLA, B and T lymphocyte
ttenuator.
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are referred to as strong responders. Although H-2b females reject
male skin or bone marrow (Simpson and Roopenian 1997; Sireci
et al. 2009), they could not reject male islet (Luo et al. 2007; Yoon
et al. 2008), kidney (Moxham et al. 2008) or cardiac grafts (He
et al. 2004). Spontaneous acceptance of male islet grafts may also
induce dominant tolerance to male antigens (Yoon et al. 2008).
Adoptive transfer of T cells from tolerant mice to female neonates
allowed acceptance of male skin grafts in the adoptive recipi-
ents, although third party grafts were not tested. Islet or heart
grafts given time to heal into the recipient before the recipient’s
immune system develops can also lead to tolerance of donor anti-
gens (Chan et al. 2007). This ‘natural tolerance’ of a transplant given
pre-immunocompetence is designed to mimic the conditions that
allow establishment of tolerance to peripheral self antigens. How-
ever, spontaneous tolerance of male islet grafts by adult mice, i.e.
tolerance of grafts given post-immunocompetence of the recipi-
ent, may not involve precisely the same mechanisms, due to the
inﬂammatory conditions associated with grafts given to immuno-
competent adult recipients and the presence of an established
adaptive immune system. It is therefore of interest to determine
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hether the primary mechanisms of peripheral self tolerance, such
s those mediated by co-inhibitory signals, are also involved in
pontaneous tolerance of weakly mismatched grafts in immuno-
ompetent recipients.
The balance between co-stimulation and co-inhibition inﬂu-
nces the outcome of immune responses by allowing strong
mmune response against appropriate foreign antigens and main-
aining tolerance to self-antigens (Sinclair and Anderson 1996;
hangavelu et al. 2010). Cytotoxic lymphocytic antigen-4 (CTLA-4;
D152), programmed death-1 (PD-1; CD279) and B and T lympho-
yte attenuator (BTLA; CD272) are some of the major co-inhibitory
olecules that have been shown to be involved in immunological
olerance. CTLA-4 is expressed by activated T cells and Tregs and can
ompete with the co-stimulatory molecule CD28 to bind with its
igands B7.1 (CD80) and B7.2 (CD86). Lack of CTLA-4 induced a fatal
ymphoprolifertive disorder in mice (Waterhouse et al. 1995) that
as recently shown to be due to autoreactive T cells (Ise et al. 2010).
D-1 shares 23% amino acid sequence homology with CTLA-4 and
s expressed by activated T cells, B cells and myeloid cells. Lack of
D-1 leads to a narrow spectrum of autoimmune disease that varies
ased on the strain background (Nishimura et al. 1999, 2001). PD-1
inds PD-L1 (B7H1; CD274) and PD-L2 (B7DC; CD273), with PD-L1
eing widely expressed in hematopoietic and non-hematopoietic
ells, whereas PD-L2 expression is restricted to dendritic cells and
acrophages (Chen et al. 2007; Keir et al. 2008). Deﬁciency of BTLA
nduced autoimmune hepatitis and anti-nuclear antibodies in aged
ice (Oya et al. 2008) and increased susceptibility to experimental
utoimmune encephalomyelitis (Watanabe et al. 2003) and aller-
ic airway inﬂammation (Deppong et al. 2006).We tested whether
he “spontaneous tolerance” of weakly mismatched transplants is
ediated by co-inhibitory pathways. Herein, we show that PD-1
lays a critical role in the tolerance of single minor mismatched
slet transplants.
aterials and methods
ice
Adult wild type C57BL/6, (B6; H-2b) mice were obtained
rom NCI (Frederick, MD). B6.129S7-Rag1tm1mom/J (abbreviated as
ag−/−) mice from Jackson were bred in house. We  generated MHC
lass-I and Rag deﬁcient mice (C57BL/6 H-2Kbtm1-H-2Dbtm1N12
ag−/−; abbreviated as class-I−/− Rag−/−) by crossing the two
nockout lines obtained originally from Jackson and the NIAID
xchange Program, NIH: 004215 C57BL/6-H-2Kbtm1-H-2Dbtm1
Pérarnau et al. 1999). MHC  class-II deﬁcient B6.129-H2-Ab1tm1Gru
abbreviated as class-II−/−) mice were from Taconic Farms.
57BL/6-Pdcd1−/− (PD-1−/−) mice, originally generated by Prof. T.
onjo and colleagues (Nishimura et al. 1998, 1999) in embryonic
tem cells of the 129/Sv background and backcrossed 11 genera-
ions to C57BL/6, and C57BL/6-BTLA−/− (BTLA−/− mice, Watanabe
t al. 2003) were bred at the University of Alberta. All protocols on
are and handling of animals were carried out in CCAC accredited
acilities at the University of Alberta.
iabetes induction and islet transplantation
Diabetes was chemically induced by a single intraperitoneal
njection of STZ; 200 mg/kg; Sigma–Aldrich in female recipients.
iabetes was conﬁrmed as blood glucose of >20 mmol/L twice on
onsecutive days. Diabetic recipients were transplanted with 400
ale donor islets into the renal subcapsular space. The function of
he graft was monitored by blood glucose; rejection was  deﬁned
s blood glucose exceeding 15 mmol/L on two consecutive days.
ephrectomy was performed to assess whether transplanted islets
ere responsible for the normoglycemic state.logy 216 (2011) 918– 924 919
In  vivo antibody treatment and immunization
We  used 250 g anti-mouse PD-1 mAb  (J43), anti-mouse PD-
L1 (10F.9g2), anti-mouse PD-L2 (TY25), and isotype control (Rat
IgG2b) given every other day, beginning on the day of trans-
plantation, for a total of six injections (last injection on day 10).
Anti-CTLA-4 (4F10), at a dose of 100 g of blocking antibody was
injected every 2 days from the day of transplantation for a total
of six injections. For sensitization experiments, anti-mouse PD-
1 was used at 250 g mAb  (J43) per injection, and given twice
to block PD-1 signaling. For sensitization, 4 × 106 male B6 or PD-
1−/− splenocytes were injected into female B6 or PD-1−/− mice
respectively. Fourteen days post immunization, all recipients were
made diabetic, as described above, and transplanted with male islet
grafts. WT  B6 recipients received male islets from WT  B6 donors,
and PD-1−/− recipients received islets from PD-1−/− male donors.
Pentamer studies
We  used PE labelled H-2Db (WMHHNMDLI; UTY 246-254;
Proimmune, Bradenton, FL) pentamers together with antibodies
to mouse CD8, pan TCR and CD19 (eBioscience, San Diego, CA)
to detect the frequency of anti-HY CD8 T cells. Non-speciﬁc bind-
ing was  blocked with anti-CD16/32 antibody (2.4G2; Bio Express,
West Lebanon, NH), and mouse, rat and hamster sera. Data acqui-
sition and analysis was  on a FACSCaliburTM ﬂow cytometer (BD
Biosciences).
Histology and immunoﬂuorescence
Kidney with islet grafts were ﬁxed in formalin, embedded in
parafﬁn, sectioned, and stained with anti-insulin, hematoxylin
and eosin. For immunoﬂuorescence 5 m crosssections were ﬁxed
with acetone and blocked with 20% normal goat serum (Jackson
ImmunoResearch Westgrove, PN). Staining was with rat anti-
mouse CD4 or CD8, (1:200; Biolegend, San Deigo, CA) followed
by goat anti-rat Alexaﬂour 488 (1:200; Invitrogen Laboratories,
Burlington, ON). Slides were coverslipped using Prolong Gold
Anti-fade with DAPI (Invitrogen), and visualized on a compound
ﬂuorescent microscope (Axioplan, Axiovision 4.1 Software, Carl
Zeiss, Toronto, ON).
Statistical analysis
Statistical analyses were done using GraphPad Prism Software
(San Diego, CA). The Kaplan–Meier method and the log rank test
were used for graft survival and a Student’s t-test for pentamer
studies.
Results
Tolerance induced by spontaneously accepted islet grafts is PD-1
dependent
Female WT  mice accepted male islet grafts indeﬁnitely (Fig. 1A),
in agreement with previous studies (Luo et al. 2007; Yoon et al.
2008). We  tested whether targeting co-inhibitory pathways pre-
vents spontaneous acceptance of male islets, by treating mice with
mAb  that block either CTLA-4 or PD-1 (Agata et al. 1996; van Wijk
et al. 2007). While we have never observed rejection of ‘syngeneic’
male islets by WT  mice, one of the recipients treated with anti-PD-
1 rejected its male islet graft (Fig. 1A), suggesting that PD-1 may
have some role in spontaneous acceptance. A preliminary analysis
using anti-PD-L1 or anti-PD-L2 treatment did not provide further
support for this hypothesis, as these antibodies did not prevent
spontaneous graft acceptance (Fig. 1B). Therefore, we tested the
920 G. Thangavelu et al. / Immunobio
Fig. 1. PD-1 is required for tolerance but not acceptance of a weakly mismatched
islet allograft. (A) Male B6 islets were transplanted to syngeneic female mice that
were either untreated (black solid line; n = 4; control) or treated with blocking anti-
bodies to CTLA-4 (grey dashed line; n = 5) or PD-1 (black dashed line; n = 5). (B) B6
male islets were transplanted to syngeneic female mice that were treated with anti-
PD-L1 (black dashed line; n = 5), anti-PD-L2 (black solid line; n = 5) or isotype control
(grey  solid line; n = 5). (C) Female PD-1−/− mice were transplanted with male PD-1−/−
or WT islet grafts (black solid line; n = 7) or female PD-1−/− islet grafts (black dashed
line; n = 3). Also, female BTLA−/− mice were transplanted with male BTLA−/− islet
grafts (grey solid line; n = 5). (D) 100–105 days post transplantation, female recip-
ients were immunized with 4 ×106 male splenocytes. The groups included female
P
l
l
n
r
w
o
w
P
o
t
i
i
t
a
a
T
P
F
i
i
GD-1−/− mice transplanted with male (black solid line; n = 4) or female (grey dashed
ine; n = 3) islets or female B6 (WT) mice transplanted with male islets (black dashed
ine; n = 4) and female BTLA−/− mice transplanted with male islets (grey solid line;
 = 5).
ole of PD-1 by two additional approaches. In the ﬁrst approach,
e gave female PD-1−/− mice male islets. In order to ensure the
nly antigenic mismatches were derived from the Y chromosome,
e used PD-1−/− mice as the donors of male islets. Again, lack of
D-1 function appeared to have at most a small effect, with only one
ut of seven recipients rejecting their graft (Fig. 1C). We  also tested
he role of BTLA, using BTLA−/− recipients. There was no increase
n rejection of male islet grafts in BTLA−/− females (Fig. 1C).Our previous studies (Luo et al. 2007) indicated that diabetes (as
nduced by STZ) could suppress the anti-HY immune response, and
his diabetes-induced immunosuppression might have reduced the
bility to detect a role for these receptors in spontaneous graft
cceptance. We  therefore tested whether the ability to maintain the
able 1
D-1 is required to prevent rejection of male islet grafts in sensitized recipients.
Group Islet donor Recipients Anti-PD-1 treatment 
1 Male PD-1−/− N/Aa
2  Female PD-1−/− N/A 
3  Male BTLA−/− None 
4 Male WT None 
5  Male WT  At immunization 
6  Male WT  At transplantation 
7  Male WT  At immunization and tra
emale WT or PD-1−/− or BTLA−/− mice were immunized with male splenocytes two  we
slets  (group 1) were signiﬁcantly different (P < 0.01) from groups 2, 3, and 4. For group
mmunization with male splenocytes or at the time of transplantation of male islets, 2 we
roup  7 vs. 4 (P < 0.05).
a N/A, not applicable.
b Group 1 recipients (n = 8) of male islets received islets from WT B6 (n = 4) or PD-1−/− Blogy 216 (2011) 918– 924
graft after immunization with donor antigen may  depend on PD-1
function. We  immunized female WT,  PD-1−/− or BTLA−/− recipi-
ents with long-term accepted grafts (100–105 days) to test if the
grafts had induced tolerance to HY or if instead the immunization
would trigger islet rejection. Interestingly, almost all of the PD-1−/−
recipients, but not WT  or BTLA−/− recipients, rejected their long-
term established graft (Fig. 1D). Together these results indicate
that despite the spontaneous islet allograft acceptance not being
strongly PD-1/PD-L1/PD-L2 dependent, the tolerance induced by
the long-term presence of the islet graft is highly dependent on
PD-1 but not BTLA function.
Spontaneous graft acceptance in sensitized recipients is PD-1
dependent
Having found that immunization with male antigen breaks the
long-term acceptance of male islet grafts in female PD-1−/− mice,
it suggested the possibility that PD-1 may  play a more critical
role in controlling the response of sensitized recipients. We  there-
fore tested the effect of sensitization with donor antigen prior to
transplantation on spontaneous graft acceptance in WT vs. PD-
1−/− or BTLA−/− recipients. Female WT,  PD-1−/− or BTLA−/− mice
were immunized with male splenocytes before islet transplanta-
tion. Similar to the immunization post transplantation data, there
was  consistent rejection (100%) of male, but not control female,
islets grafts only in the sensitized female PD-1−/− mice (Table 1).
Sensitized female PD-1−/− recipients rejected donor male islet from
either WT  B6 or PD-1−/− B6 donors, indicating that rejection was
not due to potential additional minor antigen mismatches between
WT B6 and PD-1−/− B6 mice. Lack of female islet rejection showed
the response was donor speciﬁc and not due to potential autore-
activity in PD-1−/− mice. Similarly, we  found that the PD-1−/−
recipients that rejected male islets would accept a female islet graft
and reject a second male islet graft when re-transplanted in the
contralateral kidney (data not shown). Histological examination
conﬁrmed the rejection of male islets in sensitized PD-1−/− but not
WT recipients, the latter showing strong insulin staining and only a
peri-islet inﬁltrate (Fig. 2B). Male islet grafts were inﬁltrated with
CD4 and CD8 cells in sensitized PD-1−/− mice (Fig. 2C).
Blockade of PD-1 signaling can result in the expansion of anti-
donor CD8+ T cells (Koehn et al. 2008). We  examined the frequency
of anti-HY CD8 T cells using pentamers, in sensitized female WT
or PD-1−/− mice. There was an increase in the percentage of anti-
HY CD8 T cells in sensitized female PD-1−/− mice compared to WT
mice (P < 0.05; Fig. 2A), suggesting a role for PD-1 in dampening the
priming of anti-donor T cells.
Our data indicated that PD-1 is important during the priming
stage, with increased accumulation of donor speciﬁc CD8 T cells
when PD-1 is absent during immunization. However, ligands for
PD-1 are also expressed within the islets themselves (Wang et al.
Graft survival (d) % Graft survival
10 × 2, 14, 18, 20 × 2, 28, 76b 0
>100 × 5 100
44, >100 × 3 75
>100 × 7 100
15, 16, >100 × 3 60
20, >100 × 4 80
nsplantation 17, 19, 28, >100 25
eks before transplantation of islet grafts. The sensitized PD-1−/− mice given male
s 5–7, female WT  mice were given anti-PD-1 twice (6 days apart) at the time of
eks after immunization or were given anti-PD-1 once at both stages at both stages.
6 (n = 4) donors.
G. Thangavelu et al. / Immunobiology 216 (2011) 918– 924 921
Fig. 2. Lack of PD-1 increased the frequency of anti-HY CD8 T cells. (A) Female B6 or PD-1−/− mice were immunized with male splenocytes and pentamer staining was
performed in splenocytes 2 weeks after immunization. Plots show the frequency of TCR gated pentamer positive anti-HY CD8 T cells. (B) Histological examination of
representative islet grafts from sensitized female WT (not rejected; top) showed numerous intact islets that contain insulin granules (brown) surrounded with a mononuclear
cell  inﬁltrate. Male islet grafts in sensitized female PD-1−/− recipients (rejected; middle) had substantial inﬁltrates that penetrated the islets and little if any insulin staining.
Female  islet grafts with insulin granules (brown) in sensitized female PD-1−/− recipients (not rejected; bottom). Histology was  assessed 5 days post-islet graft rejection and
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rejected) mice. Blue: staining of nucleus with 4′ ,6′-diamidino-2-phenylindole (DAP
ejection and 130 days post islet transplantation for mice that accepted the islet gra
o  the web  version of the article.)
005) and therefore lack of PD-1 signaling during the response to
he transplant could potentially also contribute to the rejection. To
xamine this question, we targeted PD-1 with mAb  speciﬁcally at
he immunization stage before transplantation or at the transplan-
ation stage or at both stages. Targeting the PD-1 pathway at both
he stages tended to be more effective than blocking at either one
f the stages alone (Table 1). Taking these results together, PD-1
ay  be required at both the priming and transplantation stages for
pontaneous allograft acceptance in sensitized recipients.uorescence pictures of male islet grafts in sensitized B6 (not rejected) or PD-1
en: CD4 or CD8 staining. Immunoﬂuorescence was assessed 2 weeks post islet graft
 interpretation of the references to color in this ﬁgure legend, the reader is referred
Loss of PD-1 leads to donor MHC  class-I but not class-II dependent
rejection
Whether direct presentation of donor antigens by islets is crit-
ical for their rejection is controversial. One study suggested donor
MHC  class-I is a major pathway in islet rejection, as class-I deﬁ-
cient islets were accepted in the majority of recipients (Markmann
et al. 1992). In contrast, Gill and colleagues (Kupfer et al. 2008)
showed that absence of donor class-I and II, but not either alone,
922 G. Thangavelu et al. / Immunobio
Fig. 3. Absence of donor class-I prevented the rejection of male islet grafts in sen-
sitized female PD-1−/− recipients. Top: Chemically induced diabetic female PD-1−/−
mice, previously sensitized with male spleen cells were transplanted with male
class-I−/− Rag−/− (black solid line; n = 5), class-II−/− (black dashed line; n = 3) or con-
trol Rag−/− (class-I & II+/+) islet grafts (grey solid line; n = 3). Bottom: Islets from male
c −/− −/− −/−
r
u
f
p
C
s
c
g
w
H
c
a
D
n
P
P
M
2
v
a
t
n
w
a
e
g
c
t
−/−lass-I Rag mice were transplanted to sensitized diabetic female B6 PD-1
ecipients (black dashed lines; n = 5). Data shown are blood glucose levels of individ-
al mice, and values for sensitized diabetic female B6 PD-1−/− recipients of control
emale islets (black solid lines; n = 5) are shown for comparison.
revented rejection. Given the increased frequency of anti-donor
D8 T cells in sensitized PD-1−/− recipients (Fig. 2), we hypothe-
ized that PD-1 deﬁciency would lead to rejection targeting donor
lass-I molecules. We  compared class-I−/− vs. class-II−/− donor islet
rafts in pre-sensitized PD-1−/− recipients. Acute graft rejection
as indeed dependent on donor class-I but not class-II (Fig. 3).
owever, the recipients of class-I−/− donors did exhibit blood glu-
ose levels close to the rejection level (Fig. 3), suggesting some
ttack on the islets could occur even in the absence of donor class-I.
iscussion
PD-1 has been shown to play an important role in the mainte-
ance of immunological tolerance (Nishimura et al. 1999, 2001).
revious studies have reported that deﬁciency or blockade of the
D-1/PD-L1 pathway prevented the prolongation or acceptance of
HC mismatched skin (Dai et al. 2009) and cardiac (Wang et al.
007; Wang et al. 2008b)  allografts, which were achieved with
arious tolerogenic regimens. Whether such induced transplant
cceptance and spontaneous acceptance would involve the same
olerance mechanisms was unknown. We  have shown here the sig-
iﬁcance of the PD-1 pathway in the spontaneous acceptance of
eakly mismatched transplants. Female H-2b mice spontaneously
ccepted syngeneic male islet grafts and an earlier study (Yoon
t al. 2008) reported that the spontaneous acceptance of male islet
rafts could induce tolerance to male antigen. We  tested whether
o-inhibitory molecules are involved in the induction of this spon-
aneous acceptance of male islet grafts. Our studies represent onlylogy 216 (2011) 918– 924
an initial test of the role of co-inhibitory molecules such as CTLA-4
and PD-1 by using speciﬁc blocking antibodies. While only anti-
PD-1 had any discernable effect in allowing rejection of male islets
by naïve recipients, and CTLA-4 seemed not to be involved, our
studies using anti-CTLA-4 are too limited to completely exclude a
role for this pathway in spontaneous allograft acceptance. A larger
study and examination of pre-sensitized recipients is required to
fully evaluate this possibility. In the case of BTLA deﬁciency, only a
weak effect was  discernable, and even then only in the sensitized
recipients.
The frequency of T cells against HY antigen in naïve female mice
is low (Simpson 1983) and CD4 T cell help is critical in the CD8
T cell response to HY (Guerder and Matzinger 1992; Keene and
Forman 1982). Blocking or loss of PD-1 signaling in naïve female
mice did not induce rejection of male islet grafts in the major-
ity of naïve female mice. This may  indicate that the HY antigens
alone are insufﬁcient to trigger islet rejection. However, an ear-
lier study (Luo et al. 2007) from our laboratory had shown that
non-diabetic female recipients induced stronger anti-HY immune
responses and more peri-islet inﬁltration of grafts than those of
diabetic female recipients. Thus, lack of rejection may also be due
to the immunosuppressive effects of STZ induced diabetes on anti-
HY immune responses (Luo et al. 2007). Hence, we tested whether
immunization with donor antigen in the absence of PD-1 signal-
ing would break the spontaneous acceptance of male islet grafts.
Immunization did indeed trigger rejection of accepted grafts in
PD-1−/− recipients. This rejection was  not a result of potential addi-
tional minor antigens on the immunizing male spleen cells, as the
immunizing cells were also from PD-1−/− mice. A second objective
of our experiment was to mimic  the situation of islet transplant
recipients, in which the recipient’s immune system may already be
sensitized to islet and/or donor antigens. Interestingly, we found
that PD-1 has a crucial role in both the long-term acceptance of
the graft after immunization with donor antigen and in initial graft
acceptance in pre-sensitized recipients.
There are at least two  possibilities that may  explain the rejec-
tion of male islet grafts in the absence or blockade of PD-1. The ﬁrst
possibility is by increasing the frequency of anti-HY CD8 T cells, as
we observed using HY/Db pentamers. Increased CD8 T cells could be
due to reduced PD-1 signals in the CD8s themselves, reduced PD-1
signals to HY speciﬁc helper T cells that promote CD8 expansion, or
due to a reduced ability to generate adaptive Treg cells (Wang et al.
2008a). In accord with our results, previous studies have shown that
loss of PD-1 or blockade of the PD-1 pathway increased the clonal
expansion or percentage of the anti-donor T cell population, respec-
tively (Koehn et al. 2008; Kroner et al. 2009). A second possibility
is the absence of PD-1/PD-L1 ligation in the target of rejection, the
islets. PD-L1 is expressed in many cells, including beta cells of the
islets (Wang et al. 2005). Lack of PD-L1/PD-1 in NOD mice (Keir et al.
2006; Wang et al. 2005), or in an induced diabetes model (Rajasalu
et al. 2010), potentiated the onset of autoimmune diabetes, which
suggested that PD-L1 and PD-1 interaction has a protective role
in islets. Therefore, we  speculated that the absence of PD-1/PD-L1
interactions within parenchymal tissues might play a role in the
rejection of male islet grafts. An earlier study (Keir et al. 2007) had
shown the importance of PD-1 at both priming and effector stages
of CD8 T cell responses, supporting this possibility. Our  data suggest
that both an increased frequency of anti-donor T cells and a lack of
PD-1 signals at the graft site contribute to the loss of spontaneous
tolerance. Consistent with a role for CD8 T cells, class-I expression
in donor islets was required for acute male islet allograft rejec-
tion in sensitized female PD-1 recipients. However, a previous
study demonstrated that class-I deﬁcient MHC  mismatched islet
allografts could be rejected in wild-type mice (Kupfer et al. 2008).
A potential explanation for the different outcomes could be the
degree of mismatches and the high frequency of donor islet reac-
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ive T cells in the previous study. In addition, we did see increased
lood glucose levels in several recipients of class-I deﬁcient islets,
uggesting some attack on the islets had occurred. Blockade of PD-
 can increase DTH like immune responses (Salama et al. 2003)
hat may  have contributed to killing of islets by a donor class-I
ndependent mechanism.
Although sensitized WT  B6 recipients had a much lower fre-
uency of HY speciﬁc CD8 T cells compared to the sensitized
D-1−/− recipients, they nevertheless had a relatively high fre-
uency of these cells. Thus, it is not yet fully clear why  sensitized WT
6 mice are unable to reject a male islet graft. However, increased
requencies of HY speciﬁc T cells, compared to naïve mice, have
een observed in mice made tolerant to HY through peptide admin-
stration (Chai et al. 2004; James et al. 2002). These data suggest that
Y speciﬁc T cell function (e.g. cytokine production or regulatory
unction) is likely to be just as important as the frequency of spe-
iﬁc T cells in determining whether HY expressing target cells are
liminated.
Our studies also have implications for understanding the regula-
ion of immune responses to chronically persistent antigen. Failure
f immune responses to clear microbes may  lead to persistent or
hronic infections, which is mainly associated with T cell dysfunc-
ion. The PD-1/PD-L1 pathway is involved in the impairment of T
ell function during chronic viral infections; blocking the PD-1/PD-
1 pathway reversed the T cell dysfunction (Barber et al. 2006;
rautmann et al. 2006). These studies of chronic antigen exposure,
nvolve responses to systemic viral antigens. Under certain condi-
ions, systemic alloantigens can stimulate immunity and yet not
e cleared by the immune system. Examples include systemically
njected donor hematopoietic cells and host alloantigens targeted
y donor T cells during GVH reactions (Chan et al. 2008; Rivas
t al. 2009). Such persistent systemic histocompatibility antigens
an switch alloimmunity (anti-donor or anti-host) into tolerance; a
olerance that may  involve a number of mechanisms, including loss
f CD4 co-receptor expression (Chan et al. 2008), and tolerogenic
ignals from PD-1 (Rivas et al. 2009). Liver allografts can lead to sys-
emic donor antigens via migration of passenger leukocytes (Starzl
t al. 1993), and the spontaneous tolerance of liver allografts also
ppears to be dependent on co-inhibitory signals, including both
D-1 and CTLA-4 (Li et al. 2005; Morita et al. 2010). From these
irus and alloantigen studies, it might be assumed that it is the
ystemic nature of persistent antigens that triggers the tolerogenic
o-inhibitory pathway. Our results suggest that spontaneous PD-
 dependent tolerance may  not be limited to situations with high
evels of systemic antigens. We  found that donor alloantigen, in
he form of an islet graft under the kidney capsule, resists rejec-
ion and induces a form of tolerance that is highly dependent on
D-1 function. Success of allograft transplantation is inﬂuenced by
arious factors. The current studies have shown that PD-1 plays a
ritical role in the spontaneous acceptance of weakly mismatched
llografts and thus supports the idea that potentiation of naturally
nduced co-inhibitory signals (Thangavelu et al. 2010), such as via
D-1 (Gao et al. 2003), could be exploited as a mechanism to achieve
ransplantation tolerance.
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